Logo image of CTRN

CITI TRENDS INC (CTRN) Stock Fundamental Analysis

USA - NASDAQ:CTRN - US17306X1028 - Common Stock

38.85 USD
-0.31 (-0.79%)
Last: 11/7/2025, 1:48:36 PM
Fundamental Rating

3

Taking everything into account, CTRN scores 3 out of 10 in our fundamental rating. CTRN was compared to 121 industry peers in the Specialty Retail industry. While CTRN seems to be doing ok healthwise, there are quite some concerns on its profitability. CTRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CTRN had negative earnings in the past year.
CTRN had a positive operating cash flow in the past year.
In multiple years CTRN reported negative net income over the last 5 years.
In multiple years CTRN reported negative operating cash flow during the last 5 years.
CTRN Yearly Net Income VS EBIT VS OCF VS FCFCTRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

The Return On Assets of CTRN (-3.64%) is worse than 65.29% of its industry peers.
Looking at the Return On Equity, with a value of -14.70%, CTRN is in line with its industry, outperforming 42.15% of the companies in the same industry.
Industry RankSector Rank
ROA -3.64%
ROE -14.7%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
CTRN Yearly ROA, ROE, ROICCTRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

CTRN has a Gross Margin of 39.75%. This is in the better half of the industry: CTRN outperforms 62.81% of its industry peers.
CTRN's Gross Margin has been stable in the last couple of years.
CTRN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
CTRN Yearly Profit, Operating, Gross MarginsCTRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

6

2. Health

2.1 Basic Checks

CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
CTRN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CTRN has less shares outstanding
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CTRN Yearly Shares OutstandingCTRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CTRN Yearly Total Debt VS Total AssetsCTRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

CTRN has an Altman-Z score of 3.10. This indicates that CTRN is financially healthy and has little risk of bankruptcy at the moment.
CTRN has a Altman-Z score of 3.10. This is in the better half of the industry: CTRN outperforms 71.90% of its industry peers.
There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.1
ROIC/WACCN/A
WACC9.34%
CTRN Yearly LT Debt VS Equity VS FCFCTRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

CTRN has a Current Ratio of 1.13. This is a normal value and indicates that CTRN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.13, CTRN is doing worse than 67.77% of the companies in the same industry.
CTRN has a Quick Ratio of 1.13. This is a bad value and indicates that CTRN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.43, CTRN is in line with its industry, outperforming 42.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 0.43
CTRN Yearly Current Assets VS Current LiabilitesCTRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

3

3. Growth

3.1 Past

CTRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -29.69%.
CTRN shows a small growth in Revenue. In the last year, the Revenue has grown by 3.32%.
CTRN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.75% yearly.
EPS 1Y (TTM)-29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.73%
Revenue 1Y (TTM)3.32%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.04%

3.2 Future

The Earnings Per Share is expected to grow by 24.07% on average over the next years. This is a very strong growth
Based on estimates for the next years, CTRN will show a small growth in Revenue. The Revenue will grow by 5.80% on average per year.
EPS Next Y78.17%
EPS Next 2Y45.99%
EPS Next 3Y33.26%
EPS Next 5Y24.07%
Revenue Next Year5.99%
Revenue Next 2Y5.68%
Revenue Next 3Y5.94%
Revenue Next 5Y5.8%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTRN Yearly Revenue VS EstimatesCTRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
CTRN Yearly EPS VS EstimatesCTRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6

2

4. Valuation

4.1 Price/Earnings Ratio

CTRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 64.56, the valuation of CTRN can be described as expensive.
Based on the Price/Forward Earnings ratio, CTRN is valued a bit more expensive than the industry average as 61.16% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 31.86, CTRN is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 64.56
CTRN Price Earnings VS Forward Price EarningsCTRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTRN is valued a bit more expensive than the industry average as 68.59% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 53.01
CTRN Per share dataCTRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

CTRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTRN's earnings are expected to grow with 33.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.99%
EPS Next 3Y33.26%

0

5. Dividend

5.1 Amount

No dividends for CTRN!.
Industry RankSector Rank
Dividend Yield N/A

CITI TRENDS INC

NASDAQ:CTRN (11/7/2025, 1:48:36 PM)

38.85

-0.31 (-0.79%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-26 2025-08-26/bmo
Earnings (Next)12-01 2025-12-01/bmo
Inst Owners90.77%
Inst Owner Change0.93%
Ins Owners10.83%
Ins Owner Change1.01%
Market Cap322.84M
Revenue(TTM)782.72M
Net Income(TTM)-16.64M
Analysts82.5
Price Target48.96 (26.02%)
Short Float %5.41%
Short Ratio4.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.13%
Min EPS beat(2)20.8%
Max EPS beat(2)185.47%
EPS beat(4)2
Avg EPS beat(4)-187.09%
Min EPS beat(4)-938.78%
Max EPS beat(4)185.47%
EPS beat(8)2
Avg EPS beat(8)-158.11%
EPS beat(12)5
Avg EPS beat(12)-68.98%
EPS beat(16)8
Avg EPS beat(16)-68.52%
Revenue beat(2)1
Avg Revenue beat(2)0.11%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.95%
Revenue beat(4)1
Avg Revenue beat(4)-1.15%
Min Revenue beat(4)-2.67%
Max Revenue beat(4)0.95%
Revenue beat(8)1
Avg Revenue beat(8)-2.27%
Revenue beat(12)3
Avg Revenue beat(12)-1.49%
Revenue beat(16)5
Avg Revenue beat(16)-1.86%
PT rev (1m)0%
PT rev (3m)24.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.71%
EPS NY rev (1m)0%
EPS NY rev (3m)19.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 64.56
P/S 0.41
P/FCF N/A
P/OCF 106.44
P/B 2.85
P/tB 2.85
EV/EBITDA 53.01
EPS(TTM)-2.97
EYN/A
EPS(NY)0.6
Fwd EY1.55%
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)0.36
OCFY0.94%
SpS94.19
BVpS13.63
TBVpS13.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.64%
ROE -14.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.75%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
F-Score6
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 67.5%
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion 58.46%
Profit Quality N/A
Current Ratio 1.13
Quick Ratio 0.43
Altman-Z 3.1
F-Score6
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)80.1%
Cap/Depr(5y)94.79%
Cap/Sales(3y)2.05%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.73%
EPS Next Y78.17%
EPS Next 2Y45.99%
EPS Next 3Y33.26%
EPS Next 5Y24.07%
Revenue 1Y (TTM)3.32%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%8.04%
Revenue Next Year5.99%
Revenue Next 2Y5.68%
Revenue Next 3Y5.94%
Revenue Next 5Y5.8%
EBIT growth 1Y58.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year124.15%
EBIT Next 3Y45.71%
EBIT Next 5Y30.92%
FCF growth 1Y-388.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.34%
OCF growth 3YN/A
OCF growth 5YN/A

CITI TRENDS INC / CTRN FAQ

What is the fundamental rating for CTRN stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTRN.


What is the valuation status of CITI TRENDS INC (CTRN) stock?

ChartMill assigns a valuation rating of 2 / 10 to CITI TRENDS INC (CTRN). This can be considered as Overvalued.


How profitable is CITI TRENDS INC (CTRN) stock?

CITI TRENDS INC (CTRN) has a profitability rating of 2 / 10.


What is the financial health of CITI TRENDS INC (CTRN) stock?

The financial health rating of CITI TRENDS INC (CTRN) is 6 / 10.


Is the dividend of CITI TRENDS INC sustainable?

The dividend rating of CITI TRENDS INC (CTRN) is 0 / 10 and the dividend payout ratio is 0%.